Groundbreaking UK Study Sheds Light on Nutritional Challenges Following Gastrostomy in ALS
A new multi-centre prospective evaluation has provided fresh insights into the nutritional trajectories of patients with amyotrophic lateral sclerosis (ALS) after gastrostomy placement. Published in Clinical Nutrition ESPEN and available online on 23 June 2026, the research underscores persistent difficulties in maintaining weight despite the intervention.
The study, led by researchers including Theocharis Stavroulakis, Sean White, Lucy Musson, and James Kime along with the PostGas study group, involved 17 sites across the United Kingdom. It followed 155 participants who underwent successful gastrostomy procedures, with detailed data on 64 individuals for the primary analysis of weight changes in the initial three months.
Understanding ALS and the Role of Gastrostomy
Amyotrophic lateral sclerosis, commonly known as ALS or motor neuron disease (MND) in some regions, is a progressive neurodegenerative condition that affects nerve cells in the brain and spinal cord. Patients often experience dysphagia, or difficulty swallowing, leading to inadequate nutritional intake, weight loss, and malnutrition. These factors are linked to poorer prognosis and reduced survival times.
Gastrostomy, typically performed as a percutaneous endoscopic gastrostomy (PEG), involves inserting a feeding tube directly into the stomach to deliver nutrition, hydration, and medications. It is a standard recommendation for ALS patients when oral intake becomes insufficient. However, questions remain about its effectiveness in halting weight decline amid the disease's catabolic effects.
Study Design and Participant Profile
This observational cohort study collected longitudinal data at gastrostomy placement (month 0) and follow-ups at three, six, and nine months. Assessments covered nutritional parameters, clinical status, functional measures such as the ALS Functional Rating Scale-Revised (ALSFRS-R), and survival outcomes.
Participants were adults with ALS experiencing nutritional decline warranting gastrostomy. The multi-centre approach across UK sites enhanced the generalisability of findings within the National Health Service context, where care pathways for MND are well-established.
Key Findings on Weight and Nutritional Intake
The primary outcome revealed a mean percentage weight change of -3.3% (standard deviation 7.4%) from placement to three months. Over half (51.6%) of those with complete data lost more than 1 kg in this period, a statistically significant decline.
Among a subset with dietary records, weight loss correlated with lower average daily energy intake (1620 kcal versus 2022 kcal) and protein consumption (64 g versus 77 g). Calculations of total daily energy expenditure (TDEE) indicated that 61.5% of participants did not meet their predicted needs.
At the three-month mark, usage patterns varied: 50% combined oral and gastrostomy feeding, 27.6% relied solely on the tube, and 22.4% were not utilising the gastrostomy. These variations highlight individual differences in disease progression and adaptation.
Photo by Jacob McGowin on Unsplash
Survival Implications and Predictive Factors
Weight loss exceeding 1 kg post-procedure was associated with shorter median survival (270 days) compared to those who maintained or gained weight. Exploratory regression analysis pointed to mean daily water intake as a potential independent predictor of better weight outcomes, though researchers noted the finding requires cautious interpretation due to study limitations.
These results align with broader evidence that malnutrition exacerbates ALS progression. Proactive monitoring of intake and adjustments to feeding regimens appear critical.
Clinical and Research Implications
The findings emphasise the necessity for tailored, ongoing nutritional support beyond the initial placement. Multidisciplinary teams, including dietitians, speech and language therapists, and neurologists, play vital roles in optimising outcomes.
For the academic community, this study exemplifies the value of prospective, multi-centre collaborations in rare disease research. It builds on prior UK efforts, such as the earlier ProGas study, by providing updated prospective data in a contemporary cohort.
Researchers interested in advancing similar work may explore opportunities in research positions focused on neurodegenerative diseases and nutrition.
Broader Context in ALS Care and Nutrition Science
Weight management in ALS remains a complex challenge influenced by hypermetabolism, reduced mobility, and respiratory complications. International guidelines from bodies like the European Society for Clinical Nutrition and Metabolism recommend early consideration of enteral feeding, yet real-world outcomes vary.
Comparative studies from other regions, including analyses in South Korea and Portugal, have reported mixed survival benefits and underscore the importance of timing and post-procedure care. The UK study adds robust evidence that insufficient caloric and fluid delivery contributes significantly to ongoing losses.
Academic institutions and teaching hospitals can integrate these insights into curricula for medical, nursing, and allied health students, preparing future clinicians for nuanced patient management.
Future Directions and Recommendations
Experts advocate for enhanced protocols involving regular TDEE assessments, personalised feeding plans, and perhaps adjunctive therapies to address catabolism. Larger trials could investigate interventions like optimised hydration strategies or combined oral-tube approaches.
Funding bodies and universities may prioritise grants for longitudinal ALS nutrition research, fostering careers in this specialised field. Job seekers with expertise in clinical trials or nutritional epidemiology will find relevant openings in faculty positions and postdoctoral roles.
Photo by Yohann LIBOT on Unsplash
Patient and Caregiver Perspectives
While the study focuses on quantitative outcomes, it implicitly highlights the lived experience of patients and families navigating feeding decisions. Education on realistic expectations and the need for vigilant follow-up can empower informed choices.
Support organisations and university-affiliated clinics often provide resources to bridge gaps between research findings and daily care.
Conclusion and Call to Action for the Academic Community
This prospective evaluation reinforces that gastrostomy alone does not guarantee nutritional stability in ALS. Sustained, individualised support is essential to improve quality of life and potentially extend survival. The work of Stavroulakis, White, Musson, Kime, and collaborators marks an important contribution to evidence-based practice.
Academics and clinicians are encouraged to review the full publication for detailed methodologies and data. Access the original article at ScienceDirect. Institutions seeking to expand research capacity in motor neuron disease or clinical nutrition may consider posting openings on specialised platforms to attract top talent.